On September 15, Moderna, Inc. fell 3.51% in regular trading, trading at $142.335 USD/share, with Turnover of $115 million.
Within the Biotechnology sector where Moderna, Inc. belongs, the overall sector performance was mixed. Among individual stocks, Vera Therapeutics up 5.14%, BIODEXA PHARMACEUTICALS up 16.07%, AbbVie down 1.16%, Gilead Sciences down 1.02%, Amgen down 1.21%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)